Vimarsana
Biggest News Aggregation in the World

Pune Based Serum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pune Based Serum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pune Based Serum Today - Breaking & Trending Today

'Covaxin was developed with safety focus': Bharat Biotech on Covishield blood clot row - Vimarsana News

'Covaxin was developed with safety focus': Bharat Biotech on Covishield blood clot row

AstraZeneca has said that in “very rare cases”, its Covid-19 vaccine can cause low platelet count and a blood clot-related side effect – Thrombosis Thrombocytopenia Syndrome (TTS)

Top vaccine maker seeks growth by selling shots to globetrotters - Vimarsana News

Top vaccine maker seeks growth by selling shots to globetrotters

Over the next three years, Pune-based Serum plans to start production of yellow fever and dengue shots for European and American travelers to countries where those diseases are endemic, Chief Executive Officer Adar Poonawalla said in an interview.

Serum Institute to send 10 lakh doses of Covishield to Nepal, Myanmar, Bangladesh - Vimarsana News

Serum Institute to send 10 lakh doses of Covishield to Nepal, Myanmar, Bangladesh

Serum Institute of India will export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh, to help them fight against the pandemic, sources said.

Injectable COVID-19 drug in works; Kolhapur's iSera Biologicals conducts trials - Vimarsana News

Injectable COVID-19 drug in works; Kolhapur's iSera Biologicals conducts trials

Adar Poonawalla-helmed Serum Institute of India has provided the technology, antigens and chemicals for the development of the drug

Nepal's fight against Covid second wave crippled by vaccine, oxygen shortage - Vimarsana News

Nepal's fight against Covid second wave crippled by vaccine, oxygen shortage

Nepal is reeling under a health crisis with limited medical facilities, shortage of oxygen and short vaccine supply.

Source: msn.com